Search research articles
Contact Us
Filters
Showing results (41-50 of 65) with videos related to
Page
of 7
Sort By:
Brain Imaging and Behavior
|
February 15, 2019
Changes in grey matter volume and functional connectivity in cluster headache versus migraine
Antonio Giorgio, Chiara Lupi, Jian Zhang, et al.
Journal of Clinical Medicine
|
April 13, 2024
Long-Term Treatment with the Calcitonin Gene-Related Peptide Receptor Antagonist Erenumab in CADASIL: Two Case Reports
Maria Albanese, Francesca Pescini, Chiara Di Bonaventura, et al.
Pharmacological Research
|
June 9, 2025
Anti-CGRP monoclonal antibodies counteract establishment of food aversive memories and chemotherapy-induced anorexia and weight loss
Alessandra Pistolesi, Simone Tuniz, Cristina Luceri, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
July 22, 2020
Low-dose methadone for refractory chronic migraine accompanied by medication-overuse headache: a prospective cohort study
Silvia Benemei, Chiara Lupi, Francesco De Cesaris, et al.
Clinical Psychology & Psychotherapy
|
November 24, 2024
Mental Pain Questionnaire: Clinimetric Properties of a Potential Global Person-Centred Outcome Measure
Fiammetta Cosci, Danilo Carrozzino, Chiara Patierno, et al.
Journal of Nephrology
|
September 24, 2002
Continuing follow-up of malignant hypertension
Paolo Tommaso Scarpelli, Marco Gallo, Francesco De Cesaris, et al.
Headache
|
January 18, 2025
Pharmacological differences and switching among anti-CGRP monoclonal antibodies: A narrative review
Marina Romozzi, Antonio Munafò, Andrea Burgalassi, et al.
Cephalalgia : an International Journal of Headache
|
November 5, 2024
Outcomes, unmet needs, and challenges in the management of patients who withdraw from anti-CGRP monoclonal antibodies: A prospective cohort study
Andrea Burgalassi, Marina Romozzi, Giulia Vigani, et al.
Cephalalgia : an International Journal of Headache
|
October 17, 2025
The clinical outcome of patients starting monoclonal antibodies anti-CGRP with concomitant migraine preventive treatments
Luisa Fofi, Claudia Altamura, Marilena Marcosano, et al.
The Journal of Headache and Pain
|
September 1, 2025
A nomogram for the prediction of response to anti-CGRP mAbs: the CGRP score
Marina Romozzi, Ammar Lokhandwala, Catello Vollono, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 65) with videos related to
Sort By:
Page
of 7
Brain Imaging and Behavior
|
February 15, 2019
Changes in grey matter volume and functional connectivity in cluster headache versus migraine
Antonio Giorgio, Chiara Lupi, Jian Zhang, et al.
Journal of Clinical Medicine
|
April 13, 2024
Long-Term Treatment with the Calcitonin Gene-Related Peptide Receptor Antagonist Erenumab in CADASIL: Two Case Reports
Maria Albanese, Francesca Pescini, Chiara Di Bonaventura, et al.
Pharmacological Research
|
June 9, 2025
Anti-CGRP monoclonal antibodies counteract establishment of food aversive memories and chemotherapy-induced anorexia and weight loss
Alessandra Pistolesi, Simone Tuniz, Cristina Luceri, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
July 22, 2020
Low-dose methadone for refractory chronic migraine accompanied by medication-overuse headache: a prospective cohort study
Silvia Benemei, Chiara Lupi, Francesco De Cesaris, et al.
Clinical Psychology & Psychotherapy
|
November 24, 2024
Mental Pain Questionnaire: Clinimetric Properties of a Potential Global Person-Centred Outcome Measure
Fiammetta Cosci, Danilo Carrozzino, Chiara Patierno, et al.
Journal of Nephrology
|
September 24, 2002
Continuing follow-up of malignant hypertension
Paolo Tommaso Scarpelli, Marco Gallo, Francesco De Cesaris, et al.
Headache
|
January 18, 2025
Pharmacological differences and switching among anti-CGRP monoclonal antibodies: A narrative review
Marina Romozzi, Antonio Munafò, Andrea Burgalassi, et al.
Cephalalgia : an International Journal of Headache
|
November 5, 2024
Outcomes, unmet needs, and challenges in the management of patients who withdraw from anti-CGRP monoclonal antibodies: A prospective cohort study
Andrea Burgalassi, Marina Romozzi, Giulia Vigani, et al.
Cephalalgia : an International Journal of Headache
|
October 17, 2025
The clinical outcome of patients starting monoclonal antibodies anti-CGRP with concomitant migraine preventive treatments
Luisa Fofi, Claudia Altamura, Marilena Marcosano, et al.
The Journal of Headache and Pain
|
September 1, 2025
A nomogram for the prediction of response to anti-CGRP mAbs: the CGRP score
Marina Romozzi, Ammar Lokhandwala, Catello Vollono, et al.
Page
of 7